The accuracy of psychiatric medication advertisements in medical journals

Journal of Nervous and Mental Disease

Volumn 196, Issue 4, 2008, Pages 267-273

  Spielmans, Glen I ^a   Thielges, Shelly A ^b   Dent, Amy L ^b   Greenberg, Roger P ^c  

^a METROPOLITAN STATE UNIVERSITY   (United States)

^b STATE UNIVERSITY OF NEW YORK AT FREDONIA   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Marketing; Medical journal policy; Psychiatric medication advertising

Indexed keywords

DONEPEZIL; MEMANTINE; PSYCHOTROPIC AGENT; RISPERIDONE; ZIPRASIDONE;

ACCURACY; ADVERTIZING; ARTICLE; DRUG COST; DRUG EFFICACY; DRUG MARKETING; HUMAN; MEDICAL LITERATURE; MENTAL DISEASE; MONOTHERAPY; PATIENT COMPLIANCE; POLICY; PSYCHIATRY; PUBLICATION; SCIENTIFIC MISCONDUCT; SIDE EFFECT; WEIGHT GAIN;

ADVERTISING AS TOPIC; COST-BENEFIT ANALYSIS; DRUG INDUSTRY; ETHICS, MEDICAL; ETHICS, PHARMACY; HUMANS; MARKETING; MENTAL DISORDERS; PERIODICALS AS TOPIC; PSYCHIATRY; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME; UNITED STATES;

EID: 42249085782     PISSN: 00223018     EISSN: None     Source Type: Journal    
DOI: 10.1097/NMD.0b013e31816a436b     Document Type: Article

References (30)

1. Accenture (2003) Physicians seek more detailed, comparative and customized information from pharmaceutical reps. Accenture research finds. Available at: http://accenture.tekgroup.com/article_display.cfm?article_id=4020. Accessed October 10, 2007.
2. Arnold M (2007) AMM ads promote power of journals. Med Mark Media. 42:20.
3. Association of Medical Publishers (undated) The value of medical journal advertising. Available at: http://www.ammonline.org/Media/ Medical_Journal_Ad_Overview.pdf. Accessed October 10, 2007.
4. Bhattacharyya T, Tornetta P III, Healy WL, Einhorn TA (2003) The validity of claims made in orthopaedic print advertisements. J Bone Joint Surg Am. 85:1224-1228.
5. Cooper RJ, Schriger DL (2005) The availability of references and the sponsorship of original research cited in pharmaceutical advertisements. CMAJ. 172:487-491.
6. Dubois RW (2003) Pharmaceutical promotion: Don't throw the baby out with the bathwater. Health Aff (Millwood). Suppl Web Exclusives: W3-96-W3-103. Available at: http://content.healthaffairs.org/cgi/content/full/hlthaff.w3. 96v1/DC1.
7. Fisher S, Greenberg RP (1993) How sound is the double-blind design for evaluating psychotropic drugs? J Nerv Ment Dis. 181:345-350.
8. Food and Drug Administration, Center for Drug Evaluation and Research (2007) Warning letters and notice of violation letters to pharmaceutical companies. Available at: http://www.fda.gov/cder/warn/index.htm. Accessed September 29, 2007.
9. Fugh-Berman A, Alladin K, Chow J (2006) Advertising in medical journals: Should current practices change? PLoS Med. 3:e130.
10. Greving JP, Denig P, de Zeeuw D, Haaijer-Ruskamp FM (2007) Claims in advertisements for antihypertensive drugs in a Dutch medical journal. J Hypertens. 25:713-722.
11. Gutknecht DR (2001) Evidence-based advertising? A survey of four major journals. J Am Board Fam Pract. 14:197-200.
12. http://www.rxpromoroi.org/rapp/exec_sum.html (undated) ROI Analysis of Pharmaceutical Promotion (RAPP): An Independent Study: Executive Summary.
13. Hunt C (2005) Interaction of detailing and drug advertising: How detailing and journal advertising impact new prescriptions. Available at: http://rxpromoroi.org/pdf/interaction_whitepaper.pdf. Accessed October 8, 2007.
14. IMS Health (2007a) Total U.S. promotional spend by type, 2006. Available at: http://imshealth.com/ims/portal/front/articleC/0,2777, 6599_80402580_81493254,00.html. Accessed October 3, 2007.
15. IMS Health (2007b) Top 10 therapeutic classes by U.S. dispensed prescriptions. Available at: http://www.imshealth.com/ims/portal/front/articleC/ 0,2777,6599_80411808_80413635,00.html. Accessed October 3, 2007.
16. IMS Health (2007c) Leading therapy classes by global pharmaceutical sales, 2006. Available at: http://www.imshealth.com/ims/portal/front/articleC/0, 2777,6599_80528184_80530441,00.html. Accessed October 3, 2007.
17. IMS Health (2007d) Top 10 therapeutic classes by U.S. sales. Available at: http://www.imshealth.com/ims/portal/front/articleC/0,2777, 6599_80408854_80411855,00.html. Accessed October 3, 2007.
18. IMS Health (2007e) Leading products by global pharmaceutical sales, 2006. Available at: http://www.imshealth.com/ims/portal/front/articleC/0,2777, 6599_80528184_80528228,00.html. Accessed October 3, 2007.
19. Lankinen KS, Levola T, Marttinen K, Puumalainen I, Helin-Salmivaara A (2004) Industry guidelines, laws and regulations ignored: Quality of drug advertising in medical journals. Pharmacoepidemiol Drug Saf. 13:789-795.
20. Loke TW, Koh FC, Ward JE (2002) Pharmaceutical advertisement claims in Australian medical publications. Med J Aust. 177:291-293.
21. Mindell J, Kemp T (1997) Evidence based advertising? Only two fifths of advertisements cited published, peer reviewed references. BMJ. 315:1622.
22. Orentlicher D, Hehir MK II (1999) Advertising policies of medical journals: Conflict of interest for journal editors and professional societies. J Law Med Ethics. 27:113-121.
23. Paul CM, May EM (2004) Seen by the doctor. Med Mark Media. 39:44 -51.
24. Pharmaceutical Research and Manufacturers of America (PhRMA) (2002) PhRMA code on interactions with healthcare professionals. Available at: http://www.phrma.org/files/PhRMA%20Code.pdf. Accessed October 2, 2007.
25. Smart S, Williams C (1997) Evidence based advertising? Half of drug advertisements in BMJ over six months cited no supporting evidence. BMJ. 315:1622-1623.
26. Thomson Scientific (2007) Journal citation reports. Available at: http://scientific.thomson.com/products/jcr/. Accessed September 20, 2007.
27. van Winkelen P, van Denderen JS, Vossen CY, Huizinga TW, Dekker FW (2006) How evidence-based are advertisements in journals regarding the subspecialty of rheumatology? Rheumatology (Oxford ). 45:1154-1157.
28. Villanueva P, Peiro S, Librero J, Pereiro I (2003) Accuracy of pharmaceutical advertisements in medical journals. Lancet. 361:27-32.
29. Wilkes MS, Doblin BH, Shapiro MF (1992) Pharmaceutical advertisements in leading medical journals: Experts' assessments. Ann Intern Med. 116. 912-919.
30. Wittink DR (2002) Analysis of ROI for pharmaceutical promotion (ARPP). Available at: http://rxpromoroi.org/arpp/media/arpp9_18dwittink.ppt. Accessed October 10, 2007.